Research

DocTIS’ results and the origin of a universal diagnostic tool for inflammatory diseases

Advancements in immune-mediated disease therapies: insights from DOCTIS project partner Pere Santamaria

New Scientific Publications from the DOCTIS Project

DOCTIS: Interview with the coordinator

Milestones in combinatorial therapies

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19